Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.

International journal of oncology - 1 Sept 2017

Obayashi Sayaka, Horiguchi Jun, Higuchi Toru, Katayama Ayaka, Handa Tadashi, Altan Bolag, Bai Tuya, Bao Pinjie, Bao Halin, Yokobori Takehiko, Nishiyama Masahiko, Oyama Tetsunari, Kuwano Hiroyuki

Abstract excerpt

Stathmin1 (STMN1) regulates progression in various cancers. The present study aimed to determine the relationship between STMN1 expression and several cancer-related markers in breast cancer. Using immunohistochemistry, we evaluated STMN1, estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67, epidermal growth factor receptor (EGFR), CK5/6, CD44, CD24, aldehyde dehydrogenase 1,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadherins
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epithelial Cell Adhesion Molecule

Share to Kaplan-Meier Estimate

Share to Neoplastic Stem Cells

Share to Stathmin

Share to Triple Negative Breast Neoplasms

Share to Tubulin

Source

Open in PubMed Open full text

Identifiers

PMID: 28766688
DOI: 10.3892/ijo.2017.4085
PMCID: PMC5564402

Genes

STMN1
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.PMID 28766688Read ↗

Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian CancerSemantic proximity Read ↗

STNM1 in human cancers: role, function and potential therapy sensitizerSemantic proximity Read ↗

Expression of markers of stem cell characteristics, epithelial-mesenchymal transition, basal-like phenotype, proliferation, and androgen receptor in metaplastic breast cancer and their prognostic impact.Semantic proximity Read ↗

MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1Semantic proximity Read ↗

Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.Semantic proximity Read ↗

Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinomaSemantic proximity Read ↗

Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups.Semantic proximity Read ↗

Suppression of Tumorigenicity 5 Ameliorates Tumor Characteristics of Invasive Breast Cancer Cells via Integrating ERK/JNK PathwaySemantic proximity Read ↗

Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.Semantic proximity Read ↗

SGCE Promotes Breast Cancer Stem Cells by Stabilizing EGFRSemantic proximity Read ↗

Comprehensive Analysis of the Expression and Prognostic Value of SPINT1/2 in Breast CarcinomaSemantic proximity Read ↗

Stathmin: a protein with many tasks. New biomarker and potential target in cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.